Artificial Joints Market Size, Share Global Analysis Report, 2026-2034

Industry Insights

[235+ Pages Report] According to Facts & Factors, the global Artificial Joints market size was estimated at USD 18.5 billion in 2025 and is expected to reach USD 32.8 billion by the end of 2034. The Artificial Joints industry is anticipated to grow by a CAGR of 6.5% between 2026 and 2034. The Artificial Joints Market is driven by the rising incidence of osteoarthritis and the increasing geriatric population globally.

Market Overview

The artificial joints market encompasses prosthetic devices designed to replace damaged or diseased natural joints, such as hips, knees, and shoulders, using biocompatible materials like metals, ceramics, and polymers to restore mobility and alleviate pain in patients suffering from arthritis or injuries. This market focuses on implantable solutions that mimic natural joint function through advanced engineering, emphasizing durability, biocompatibility, and minimally invasive implantation techniques to improve quality of life without relying on pharmacological treatments alone.

Key Insights

• As per the analysis shared by our research analyst, the global Artificial Joints market is estimated to grow annually at a CAGR of around 6.5% over the forecast period (2026-2034).
• In terms of revenue, the global Artificial Joints market size was valued at around USD 18.5 billion in 2025 and is projected to reach USD 32.8 billion by 2034.
• The global Artificial Joints market is projected to grow at a significant rate due to advancements in implant materials and rising demand for joint replacement surgeries.
• Based on the Type, the Knee Joints segment accounted for the largest market share of around 45% in 2025, due to the high prevalence of knee osteoarthritis and sports-related injuries.
• Based on the Material, the Metal-on-Polyethylene segment accounted for the largest market share of around 50% in 2025, due to its cost-effectiveness and proven long-term durability in load-bearing applications.
• Based on the End-User, the Hospitals segment accounted for the largest market share of around 60% in 2025, due to the availability of specialized surgical teams and advanced operating facilities.
• Based on region, North America was the leading revenue generator in 2025, with 40% share, due to high healthcare expenditure and advanced orthopedic care infrastructure.

Growth Drivers

• Rising Incidence of Osteoarthritis and Geriatric Population

The increasing prevalence of degenerative joint diseases among the elderly has heightened the need for artificial joints, as they provide effective pain relief and mobility restoration, driving demand in orthopedic surgeries. This driver is supported by lifestyle factors like obesity and sedentary habits, leading to earlier joint wear.

Technological improvements in implant designs, such as 3D-printed customized joints, enhance fit and longevity, attracting more patients. As global life expectancy rises, this growth driver sustains market expansion through expanded access to elective procedures.

Restraints

• High Costs of Implants and Surgeries

The substantial expenses associated with artificial joints and related procedures limit accessibility in low-income regions, where insurance coverage may be inadequate. This restraint is compounded by post-operative care costs, affecting adoption rates.

Regulatory delays for new implant approvals increase development timelines, hindering innovation. These factors collectively slow market penetration, particularly for advanced materials.

Opportunities

• Advancements in 3D Printing and Personalized Implants

Customized joint solutions via 3D printing offer better outcomes, opening avenues in precision medicine for orthopedics. This opportunity leverages digital health trends, attracting R&D investments.

Expansion into emerging markets with improving healthcare offers growth through affordable options. As robotics integrates, this could diversify applications.

Challenges

• Risk of Implant Failures and Revisions

Complications like infections or loosening require revision surgeries, eroding patient confidence. This challenge demands better biomaterials.

Supply chain issues for rare metals disrupt production. These challenges necessitate quality controls and research.

Report Scope

Report Attribute	Details
Market Size 2025	USD 18.5 Billion
Projected Market Size in 2034	USD 32.8 Billion
CAGR Growth Rate	6.5% CAGR
Base Year	2025
Forecast Years	2026-2034
Key Market Players	Zimmer Biomet Holdings Inc., Stryker Corporation, Johnson & Johnson (DePuy Synthes), Smith & Nephew Plc, Medtronic Plc, and Others.
Key Segment	By Type, By Material, By End-User, and By Region
Major Regions Covered	North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
Purchase Options	Request customized purchase options to meet your research needs. Explore purchase options

Market Segmentation

The Artificial Joints market is segmented by Type, Material, End-User, and region.

Based on Type Segment, the Artificial Joints market is divided into Hip Joints, Knee Joints, Shoulder Joints, Elbow Joints, and others. The most dominant segment is Knee Joints, which holds the largest share due to the high volume of knee replacement surgeries driven by osteoarthritis prevalence; it drives the market by supporting aging populations with mobility solutions, increasing procedure rates globally. The second most dominant is Hip Joints, common in fracture repairs; this segment contributes to market growth by addressing trauma cases, enhancing post-surgical recovery.

Based on Material Segment, the Artificial Joints market is divided into Metal-on-Metal, Metal-on-Polyethylene, Ceramic-on-Ceramic, Ceramic-on-Polyethylene, and others. The most dominant segment is Metal-on-Polyethylene, commanding the highest share because of its balance of strength and flexibility at lower costs; it propels market expansion by being widely used in standard implants, making surgeries affordable. The second most dominant is Ceramic-on-Ceramic, preferred for longevity; this segment advances the market by reducing wear in young patients, extending implant life.

Based on End-User Segment, the Artificial Joints market is divided into Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers, and others. The most dominant segment is Hospitals, with the largest share owing to comprehensive care for complex cases; it fuels market growth by handling high volumes, adopting new tech. The second most dominant is Ambulatory Surgical Centers, for outpatient efficiency; it supports market development by lowering costs, promoting day surgeries.

Recent Developments

• In 2025, Zimmer Biomet launched a 3D-printed knee implant with enhanced biocompatibility.
• In 2024, Stryker acquired a robotics firm to integrate AI in joint replacements.
• In 2023, Johnson & Johnson introduced ceramic hip implants with reduced friction.

Regional Analysis

• North America to dominate the global market

North America dominates the global artificial joints market, driven by high healthcare spending and advanced surgical techniques that facilitate widespread adoption of innovative implants. The region's robust insurance coverage supports elective procedures. The United States emerges as the dominating country, with its leading orthopedic centers and companies like Zimmer Biomet driving R&D in customized joints, supported by FDA approvals that accelerate market entry for new materials.

Europe holds a prominent position in the global artificial joints market, benefiting from universal healthcare and focus on minimally invasive surgeries. Germany stands out as the dominating country, leveraging its engineering for durable implants, aligned with EU regulations promoting patient safety.

Asia Pacific is rapidly expanding in the global artificial joints market, fueled by aging populations and medical tourism. China leads as the key country, with hospital expansions adopting affordable implants, supported by government health reforms.

Latin America is emerging in the global artificial joints market, spurred by improving access to orthopedics. Brazil dominates, implementing knee devices in public health, with partnerships aiding affordability.

The Middle East & Africa region is gradually adopting the global artificial joints market, driven by expatriate healthcare. The UAE leads, integrating hip systems in luxury hospitals, with vision plans attracting vendors.

Competitive Analysis

The global Artificial Joints market is dominated by players:

• Zimmer Biomet Holdings Inc.
• Stryker Corporation
• Johnson & Johnson (DePuy Synthes)
• Smith & Nephew Plc
• Medtronic Plc
• Exactech Inc.
• MicroPort Scientific Corporation
• B. Braun Melsungen AG
• DJO Global Inc.
• Limacorporate S.p.A.

The global Artificial Joints market is segmented as follows:

By Type

• Hip Joints
• Knee Joints
• Shoulder Joints
• Elbow Joints
• Others

By Material

• Metal-on-Metal
• Metal-on-Polyethylene
• Ceramic-on-Ceramic
• Ceramic-on-Polyethylene
• Others

By End-User

• Hospitals
• Orthopedic Clinics
• Ambulatory Surgical Centers
• Others

By Region

• North America
  • The U.S.
  • Canada
  • Mexico
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• The Middle East & Africa
  • Saudi Arabia
  • UAE
  • Egypt
  • Kuwait
  • South Africa
  • Rest of the Middle East & Africa
• Latin America
  • Brazil
  • Argentina
  • Rest of Latin America